Stephanie Weiss, M.D., Ph.D., assistant director for the Clinical Research, Medication Development Program at NIDA, shared data from the first published clinical trial of GLP-1 RAs in alcohol use disorder: in patients with obesity with a BMI over 30, exenatide reduced heavy drinking days by 23.6% and lowered total alcohol intake
Dermatologists often recommend pairing antioxidants like Vitamin C with barrier-supporting ingredients like niacinamide to reduce irritation while targeting pigmentation
Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, et al
Users must weigh this cost against the potential for faster, more complete recovery and reduced time away from work or activities
This translates into muscle growth, faster recovery from injuries, and better overall physical health when using Ipamorelin